Related Experiment Video
Updated: Jul 6, 2026
10:49
Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
Where have All the Antibiotics Gone?
1Department of Microbiology and Immunology, Life Sciences Institute, Vancouver, British Columbia.
Summary
Antibiotic resistance is a growing threat, with fewer new drugs available to treat infections. Researchers are exploring alternative strategies to combat increasingly untreatable microbial diseases.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Antibiotics revolutionized infectious disease treatment, but microbial resistance has surged.
- The pipeline for new antibiotics has dwindled, creating a therapeutic gap.
- Many bacterial infections are becoming untreatable with current antimicrobial agents.
Purpose of the Study:
- To highlight the escalating crisis of antibiotic resistance.
- To underscore the urgent need for novel antimicrobial agents.
- To explore alternative therapeutic strategies beyond traditional antibiotics.
Main Methods:
- Review of current trends in antibiotic discovery and resistance.
- Analysis of the pharmaceutical industry's reduced investment in antibiotic research.
- Investigation into emerging alternative treatments for infectious diseases.
Main Results:
- A significant increase in antibiotic-resistant microbial strains.
- A concurrent decline in the development of new therapeutic antibiotics.
- Identification of various alternative approaches being explored.
Conclusions:
- The rise of antimicrobial resistance poses a critical global health challenge.
- Urgent action is needed to revitalize antibiotic discovery and development.
- Alternative strategies are essential to manage untreatable infections.
Related Concept Videos
00:57Antibiotic Selection
Overview
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...